Dudediligence.

Incyte Corporation

INCYNASDAQ · Services-Commercial Physical & Biological Research
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$107.3M

47 notices · 1,041,408 sh

Oct 2025 to Oct 2026

Reported ·

$39.8M

25 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

All 25 reported sales carry the 10b5-1 box. Together they are 0.19% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-15: PABLO CAGNONI, Form 1442026-08-19: PABLO CAGNONI, Form 1442026-08-12: PABLO CAGNONI, Form 1442026-08-05: PABLO CAGNONI, Form 1442026-08-05: PATRICK A MAYES, Form 1442026-08-03: PATRICK A MAYES, Form 1442026-07-31: PATRICK A MAYES, Form 1442026-07-31: PABLO CAGNONI, Form 1442026-07-16: STEVEN STEIN, Form 1442026-07-16: MOHAMED ISSA, Form 1442026-07-15: STEVEN STEIN, Form 1442026-06-04: THOMAS R TRAY, Form 1442026-05-26: THOMAS R TRAY, Form 1442026-05-19: PAUL J. CLANCY, Form 1442026-04-17: PABLO CAGNONI, Form 1442026-03-17: PABLO CAGNONI, Form 1442026-02-19: PABLO CAGNONI, Form 1442026-02-09: VIJAY IYENGAR, Form 1442026-01-07: MOHAMED ISSA, Form 1442026-01-06: VIJAY IYENGAR, Form 1442026-01-05: VIJAY IYENGAR, Form 1442026-01-05: STEVEN STEIN, Form 1442025-12-19: VIJAY IYENGAR, Form 1442025-12-19: THOMAS R TRAY, Form 1442025-12-18: THOMAS R TRAY, Form 1442025-12-17: MICHAEL MORRISSEY, Form 1442025-12-16: VIJAY IYENGAR, Form 1442025-12-16: MICHAEL MORRISSEY, Form 1442025-12-15: CHRISTIANA STAMOULIS, Form 1442025-12-11: PATRICK A MAYES, Form 1442025-12-10: VIJAY IYENGAR, Form 1442025-12-10: PATRICK A MAYES, Form 1442025-12-02: STEVEN STEIN, Form 1442025-12-01: STEVEN STEIN, Form 1442025-11-24: THOMAS R TRAY, Form 1442025-11-21: THOMAS R TRAY, Form 1442025-11-17: SHEILA DENTON, Form 1442025-11-12: CHRISTIANA STAMOULIS, Form 1442025-11-10: HERVE HOPPENOT, Form 1442025-11-05: STEVEN STEIN, Form 1442025-11-04: SHEILA DENTON, Form 1442025-11-03: CHRISTIANA STAMOULIS, Form 1442025-11-03: LEE HEESON, Form 1442025-10-30: CHRISTIANA STAMOULIS, Form 1442025-10-27: BARRY FLANNELLY, Form 1442025-10-16: BARRY FLANNELLY, Form 1442025-10-15: SHEILA DENTON, Form 1442025-10-15: Denton Sheila A., sold2025-11-03: Heeson Lee, sold2025-11-04: Denton Sheila A., sold2025-11-05: Stein Steven H, sold2025-11-10: Hoppenot Herve, sold2025-11-17: Denton Sheila A., sold2025-11-21: Tray Thomas, sold2025-12-01: Stein Steven H, sold2025-12-10: Mayes Patrick A, sold2025-12-16: Morrissey Michael James, sold2025-12-18: Tray Thomas, sold2026-01-05: Stein Steven H, sold2026-01-07: Issa Mohamed Khairie, sold2026-02-19: CAGNONI PABLO J, sold2026-03-17: CAGNONI PABLO J, sold2026-04-17: CAGNONI PABLO J, sold2026-05-19: Clancy Paul J, sold2026-05-26: Tray Thomas, sold2026-06-04: Tray Thomas, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-15PABLO CAGNONI, President, Global Head of R&D$2,797,571
23,218 shplan 2026-04-30Form 4s on file end Jun 23144 ↗
2026-08-19PABLO CAGNONI, President, Global Head of R&D$1,356,190
10,801 shplan 2026-04-30Form 4s on file end Jun 23144 ↗
2026-08-12PABLO CAGNONI, President, Global Head of R&D$1,296,774
10,803 shplan 2026-04-30Form 4s on file end Jun 23144 ↗
2026-08-05PABLO CAGNONI, President, Global Head of R&D$1,305,450
10,640 shplan 2026-04-30Form 4s on file end Jun 23144 ↗
2026-08-05PATRICK A MAYES, EVP & Chief Scientific Officer$273,646
2,207 shplan 2026-04-29Form 4s on file end Jun 23144 ↗
2026-08-03PATRICK A MAYES, EVP & Chief Scientific Officer$729,204
6,055 shplan 2026-04-29Form 4s on file end Jun 23144 ↗
2026-07-31PATRICK A MAYES, EVP & Chief Scientific Officer$5,005,186
41,899 shplan 2026-04-29Form 4s on file end Jun 23144 ↗
2026-07-31PABLO CAGNONI, President, Global Head of R&D$1,901,833
15,888 shplan 2026-04-30Form 4s on file end Jun 23144 ↗
2026-07-16STEVEN STEIN, CMO & Head of Late-Stage Dev.$215,339
1,877 shplan 2025-08-06Form 4s on file end Jun 23144 ↗
2026-07-16MOHAMED ISSA, EVP, Head of US Oncology$125,706
1,093 shplan 2025-09-15Form 4s on file end Jun 23144 ↗
2026-07-15STEVEN STEIN, CMO & Head of Late-Stage Dev.$3,192,255
28,237 shplan 2025-08-06Form 4s on file end Jun 23144 ↗
2026-06-04THOMAS R TRAY, Principal Accounting Officer$263,900
2,639 shplan 2026-02-24144 ↗
Form 4, 2026-06-08: sold 2,639 at $100.00 Form 4 ↗
2026-05-26THOMAS R TRAY, Principal Accounting Officer$199,665
2,051 shplan 2026-02-24144 ↗
Form 4, 2026-05-28: sold 2,051 at $97.35 Form 4 ↗
2026-05-19PAUL J. CLANCY, Director$1,424,006
15,000 shplan 2026-02-12144 ↗
Form 4, 2026-05-21: sold 15,000 at $94.93 Form 4 ↗
2026-04-17PABLO CAGNONI, President, Global Head of R&D$1,801,326
18,667 shplan 2025-11-20144 ↗
Form 4, 2026-04-21: sold 18,667 at $96.50 Form 4 ↗
2026-03-17PABLO CAGNONI, President, Global Head of R&D$1,759,102
18,667 shplan 2025-11-20144 ↗
Form 4, 2026-03-19: sold 18,667 at $94.24 Form 4 ↗
2026-02-19PABLO CAGNONI, President, Global Head of R&D$1,883,797
18,668 shplan 2025-11-20144 ↗
Form 4, 2026-02-23: sold 18,668 at $100.91 Form 4 ↗
2026-02-09VIJAY IYENGAR, EVP, GMAPPS$1,388,987
12,743 shno plan dateno Form 4 on file144 ↗
2026-01-07MOHAMED ISSA, EVP, Head of US Oncology$1,184,051
10,856 shplan 2025-09-15144 ↗
Form 4, 2026-01-08: sold 10,856 at $109.07 Form 4 ↗
2026-01-06VIJAY IYENGAR, EVP, GMAPPS$9,998,256
95,811 shno plan dateno Form 4 on file144 ↗
2026-01-05VIJAY IYENGAR, EVP, GMAPPS$1,689,888
16,437 shno plan dateno Form 4 on file144 ↗
2026-01-05STEVEN STEIN, CMO & Head of Late-Stage Dev.$1,589,995
15,634 shplan 2025-08-06144 ↗
Form 4, 2026-01-07: sold 15,634 at $101.70 Form 4 ↗
2025-12-19VIJAY IYENGAR, EVP, GMAPPS$5,385,677
52,941 shno plan dateno Form 4 on file144 ↗
2025-12-19THOMAS R TRAY, Principal Accounting Officer$277,400
2,774 shplan 2025-08-22no Form 4 on file144 ↗
2025-12-18THOMAS R TRAY, Principal Accounting Officer$58,950
600 shplan 2025-08-22144 ↗
Form 4, 2025-12-22: sold 3,374 at $99.69 Form 4 ↗
2025-12-17MICHAEL MORRISSEY, EVP, Head of Tech. Operations$420,455
4,323 shplan 2025-09-16no Form 4 on file144 ↗
2025-12-16VIJAY IYENGAR, EVP, GMAPPS$1,317,245
13,388 shno plan dateno Form 4 on file144 ↗
2025-12-16MICHAEL MORRISSEY, EVP, Head of Tech. Operations$5,254,458
54,008 shplan 2025-09-16144 ↗
Form 4, 2025-12-18: sold 58,331 at $97.29 Form 4 ↗
2025-12-15CHRISTIANA STAMOULIS, EVP & Chief Financial Officer$18.2M
187,690 shno plan dateno Form 4 on file144 ↗
2025-12-11PATRICK A MAYES, EVP & Chief Scientific Officer$24,210
255 shplan 2025-09-08no Form 4 on file144 ↗
2025-12-10VIJAY IYENGAR, EVP, GMAPPS$2,206,695
23,104 shno plan dateno Form 4 on file144 ↗
2025-12-10PATRICK A MAYES, EVP & Chief Scientific Officer$530,756
5,553 shplan 2025-09-08144 ↗
Form 4, 2025-12-12: sold 5,808 at $95.55 Form 4 ↗
2025-12-02STEVEN STEIN, CMO & Head of Late-Stage Dev.$2,060,978
20,105 shplan 2025-08-06no Form 4 on file144 ↗
2025-12-01STEVEN STEIN, CMO & Head of Late-Stage Dev.$263,482
2,559 shplan 2025-08-06144 ↗
Form 4, 2025-12-03: sold 22,664 at $102.56 Form 4 ↗
2025-11-24THOMAS R TRAY, Principal Accounting Officer$61,800
600 shplan 2025-08-22no Form 4 on file144 ↗
2025-11-21THOMAS R TRAY, Principal Accounting Officer$17,238
169 shplan 2025-08-22144 ↗
Form 4, 2025-11-25: sold 769 at $102.78 Form 4 ↗
2025-11-17SHEILA DENTON, EVP & General Counsel$29,012
278 shplan 2024-11-27144 ↗
Form 4, 2025-11-19: sold 278 at $104.36 Form 4 ↗
2025-11-12CHRISTIANA STAMOULIS, EVP & Chief Financial Officer$811,178
7,442 shno plan dateno Form 4 on file144 ↗
2025-11-10HERVE HOPPENOT, Officer, Director$19.8M
187,500 shplan 2025-08-11144 ↗
Form 4, 2025-11-12: sold 187,500 at $105.46 Form 4 ↗
2025-11-05STEVEN STEIN, CMO & Head of Late-Stage Dev.$534,813
5,233 shplan 2025-08-06144 ↗
Form 4, 2025-11-07: sold 5,233 at $102.20 Form 4 ↗
2025-11-04SHEILA DENTON, EVP & General Counsel$60,613
598 shplan 2024-11-27144 ↗
Form 4, 2025-11-06: sold 598 at $101.36 Form 4 ↗
2025-11-03CHRISTIANA STAMOULIS, EVP & Chief Financial Officer$2,161,367
22,113 shno plan dateno Form 4 on file144 ↗
2025-11-03LEE HEESON, EVP, Head of Incyte Intl$289,017
3,074 shplan 2025-08-04144 ↗
Form 4, 2025-11-05: sold 3,074 at $94.02 Form 4 ↗
2025-10-30CHRISTIANA STAMOULIS, EVP & Chief Financial Officer$1,408,684
14,986 shno plan dateno Form 4 on file144 ↗
2025-10-27BARRY FLANNELLY, EVP & General Manager US$3,068,539
33,452 shno plan dateno Form 4 on file144 ↗
2025-10-16BARRY FLANNELLY, EVP & General Manager US$1,708,609
18,495 shno plan dateno Form 4 on file144 ↗
2025-10-15SHEILA DENTON, EVP & General Counsel$23,581
277 shplan 2024-11-27144 ↗
Form 4, 2025-10-17: sold 277 at $85.13 Form 4 ↗